COVID-19 has magnified the importance of life sciences by highlighting the need for the critical innovation life sciences firms are using to solve the current health crisis and to assist with solutions to other long-term health challenges.
Life sciences companies are seeking solutions to these challenges through the development of new drugs, therapies, and devices that can cost effectively cure disease or improve the quality of life for patients across the healthcare spectrum. Despite a thriving entrepreneurial approach, the European life sciences market is less mature on a global scale when compared to more established regions like the United States and China.
Read the full ’Thought Leadership’ article now at the link below
Supporting documentsClick link to download and view these files
- PDF, Size 0.98 mb